NOTICE OF RESULT OF CONSENT SOLICITATION

Travelex Issuerco 2 Plc ("Travelex")

4 June 2026

Travelex announces results of consent solicitation in relation to Notes Reduction and Proceeds Loan Reduction

Further to its announcement dated 5 May 2026, Travelex is pleased to announce that the consent solicitation in respect of the 3.01% Senior Guaranteed Secured Notes due 2029 (Reg S: ISIN: XS2248458049; Common Code: 224845804 / Rule 144A: ISIN: XS2248458551; Common Code: 224845855) (the "Sterling Last-Out Notes"); the 15% Senior Guaranteed Secured Notes due 2028 (Reg S: ISIN: XS3194920388; Common Code: 319492038 / Rule 144A: ISIN: XS3194920628; Common Code: 319492062) (the "Sterling First-Out Notes"); and the 3.01% Senior Guaranteed Secured Notes due 2029 (Reg S: ISIN: XS2248456936; Common Code: 224845693 / Rule 144A: ISIN: XS2248457405; Common Code: 224845740) (the "Euro Notes" and together with the Sterling Last-Out Notes, the "Last-Out Notes", and the Last-Out Notes together with the Sterling First-Out Notes, the "Notes") has concluded with the requisite majority of noteholders approving the Notes Reduction and the Proceeds Loans Reduction as detailed in the Notice of Written Resolution dated 5 May 2026.

In order to implement the noteholder approved Notes Reduction and Proceeds Loans Reduction: (i) the Notes Trustee subsequently instructed the Clearing Systems to apply the pool factor adjustment to effect the Notes Reduction; and (ii) the Company entered into an amendment to the Proceeds Loans Agreements to effect the Proceeds Loan Reduction.

Enquiries:

Travelex

For investor related queries:

Victoria.Benis-Lonsdale@travelex.com

For other enquiries:

Press@travelex.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.